Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H

BACKGROUND: Acquired resistance to imatinib is frequently caused by secondary KIT mutations. We have investigated the effects of imatinib in mice with human gastrointestinal stromal tumour (GIST) xenograft which harbours a primary exon 11 deletion mutation and a secondary imatinib resistance mutatio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Revheim, Mona-Elisabeth, Kristian, Alexandr, Malinen, Eirik, Bruland, Øyvind Sverre, Berner, Jeanne-Marie, Holm, Ruth, Joensuu, Heikki, Seierstad, Therese
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Informa Healthcare 2013
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3622233/
https://ncbi.nlm.nih.gov/pubmed/23480638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/0284186X.2013.770920
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak